Repro Med Systems, Inc

(NASDAQ:KRMD)

Latest On Repro Med Systems, Inc (KRMD):

Date/Time Type Description Signal Details
2023-05-07 15:51 ESTNewsKORU Medical Systems, Inc. (KRMD) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 21:04 ESTNewsKORU Medical Systems reports Q1 results, reaffirms FY 2023 revenue guidanceN/A
2023-03-11 09:11 ESTNewsKORU Medical Systems: Mixed OutlookN/A
2023-03-09 11:43 ESTNewsKORU Medical Systems, Inc. (KRMD) Q4 2022 Earnings Call TranscriptN/A
2023-03-08 21:04 ESTNewsRepro Med Systems GAAP EPS beats by $0.02, revenue misses by $0.04M, guidance above consensusN/A
2023-01-25 12:27 ESTNewsKoru inks pact to develop Freedom infusion system with prefilled syringeN/A
2022-11-13 10:12 ESTNewsKORU Medical Systems, Inc. (KRMD) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 18:40 ESTNewsRepro Med Systems GAAP EPS of -$0.03 beats by $0.02, revenue of $7.76M beats by $0.99MN/A
2022-08-07 18:17 ESTNewsKORU Medical Systems, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-07 18:17 ESTNewsKORU Medical Systems, Inc. (KRMD) CEO Linda Tharby on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 06:30 ESTNewsRepro Med Systems Non-GAAP EPS of -$0.06 in-line, revenue of $6.54M beats by $0.25MN/A
2022-05-08 08:57 ESTNewsRepro Med Systems, Inc. (KRMD) CEO Linda Tharby on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 19:58 ESTNewsRepro Med Systems Non-GAAP EPS of -$0.05 beats by $0.01, revenue of $6.24M beats by $0.17MN/A
2022-04-19 01:24 ESTNewsKORU Medical Systems appoints Brian Case as CTON/A
2022-03-03 06:02 ESTNewsRepro Med Systems GAAP EPS of -$0.02 beats by $0.01, revenue of $6.5M beats by $0.44MN/A
2022-03-03 06:02 ESTNewsRepro Med Systems, Inc. (KRMD) CEO Linda Tharby on Q4 2021 Results - Earnings Call TranscriptN/A
2021-12-22 10:27 ESTNewsRepro Med wins FDA clearance to expand use of FREEDOM60 Infusion SystemN/A
2021-11-10 22:58 ESTNewsRepro Med Systems EPS in-line, beats on revenueN/A
2021-11-10 22:58 ESTNewsKORU Medical shares surge 19% after 510k clearance for FreedomEdge infusion pumpN/A
2021-11-10 22:58 ESTNewsRepro Med Systems, Inc. (KRMD) CEO Linda Tharby on Q3 2021 Results - Earnings Call TranscriptN/A
2021-09-22 17:55 ESTNewsRepro Med Systems EPS misses by $0.01, beats on revenueN/A
2021-08-12 10:17 ESTNewsKORU Medical Systems, Inc. (KRMD) CEO Linda Tharby on Q2 2021 Results - Earnings Call TranscriptN/A
2021-03-24 12:21 ESTNewsRepro Med Systems, Inc. (KRMD) Interim CEO Jim Beck on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-19 08:54 ESTNewsRepro Med Systems names Linda Tharby chief executive officerN/A
2021-01-27 09:54 ESTAnalyst RatingThe Analyst Target Price has decreased from $10.13 to $8.13.Neutral
2021-01-26 09:54 ESTAnalyst RatingThe Analyst Target Price has decreased from $11.25 to $10.13.Neutral
2021-01-26 03:08 ESTNewsRepro Med Systems provides FY20 results; announces CEO transitionN/A
2021-01-11 12:49 ESTNewsKORU Medical Systems: A Razor And Razor Blade StoryN/A
2021-01-04 04:52 ESTNewsPortfolio Manager Diary: Contrast The Information Obtained By The Company Management Before InvestingN/A
2020-12-04 18:58 ESTFinancialsCompany financials have been released.Neutral
2020-12-04 10:45 ESTAnalyst RatingThe Analyst Target Price has increased from $10.2 to $11.25.Buy
2020-11-27 00:23 ESTFinancialsCompany financials have been released.Neutral
2020-11-19 07:53 ESTNewsRepro Med Systems: Fair View Of The FundamentalsN/A
2020-11-19 07:52 ESTNewsRepro Med Systems (KRMD) Investor Presentation - SlideshowN/A
2020-11-18 04:28 ESTNewsRepro Med Systems launches $10M buyback programN/A
2020-11-07 19:29 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 14:29 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 10:27 ESTAnalyst RatingThe Analyst Target Price has decreased from $10.8 to $10.2.Neutral
2020-11-06 00:02 ESTNewsRepro Med Systems, Inc.'s (KRMD) CEO Donald Pettigrew on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-06 00:01 ESTNewsRepro Med Systems, Inc. 2020 Q3 - Results - Earnings Call PresentationN/A
2020-11-05 10:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.4 to $10.8.Neutral
2020-11-04 20:12 ESTNewsRepro Med Systems EPS misses by $0.01, misses on revenueN/A
2020-11-04 10:18 ESTEarnings EstimateAn EPS average of $0.02 is estimated for the quarter ending on March 31, 2021.Buy
2020-10-08 20:35 ESTFinancialsCompany financials have been released.Neutral
2020-10-02 19:11 ESTInsider TradeJoseph M. Jr. Manko has acquired 1,039 shares indirectly via Horton Capital Partners Fund, LP.Buy
2020-10-02 17:41 ESTInsider TradeDaniel S Goldberger has directly acquired 866 shares and currently holds 98,274 shares.Buy
2020-10-02 17:41 ESTInsider TradeDavid W Anderson has directly acquired 1,039 shares and currently holds 37,978 shares.Buy
2020-10-02 17:41 ESTInsider TradeJames M Beck has directly acquired 1,039 shares and currently holds 48,336 shares.Buy
2020-10-02 17:41 ESTInsider TradeKathy Frommer has directly acquired 866 shares and currently holds 706,579 shares.Buy
2020-10-02 17:41 ESTInsider TradeR JOHN FLETCHER has directly acquired 2,597 shares and currently holds 28,998 shares.Buy

About Repro Med Systems, Inc (KRMD):

Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.

KRMD Quotes by TradingView

See Advanced Chart

General

  • Name Repro Med Systems, Inc
  • Symbol KRMD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • Full Time Employees 71
  • Fiscal Year EndDecember
  • IPO Date1996-03-20
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Web URLhttp://www.korumedical.com
View More

Valuation

  • Trailing PE 398.47
  • Forward PE 192.31
  • Price/Sales (Trailing 12 Mt.) 6.04
  • Price/Book (Most Recent Quarter) 4.27
  • Enterprise Value Revenue 5.25
  • Enterprise Value EBITDA 39.34
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate $0.02
  • Profit Margin -2%
  • Operating Margin 12%
  • Return on Assets 7%
  • Return on Equity -2%
  • Revenue 26.34 million
  • Earnings Per Share $0.02
  • Revenue Per Share $0.64
  • Gross Profit 14.85 million
  • Quarterly Earnings Growth -8.1%
View More

Highlights

  • Market Capitalization 171.82 million
  • EBITDA 3.59 million
  • Analyst Target Price $8.13
View More

Share Statistics

  • Shares Outstanding 43.94 million
  • Shares Float 27.3 million
  • % Held by Insiders 1031%
  • % Held by Institutions 65.79%
  • Shares Short 1.43 million
  • Shares Short Prior Month 1.52 million
  • Short Ratio 1.93
  • Short % of Float 7%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 0.28
  • 52 Week High $12.84
  • 52 Week Low $3.27
  • 50 Day Moving Average 4.06
  • 200 Day Moving Average 5.48
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Repro Med Systems, Inc (KRMD) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Repro Med Systems, Inc (KRMD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-04$6.08 million$0.01$0.02-68%
2020-06-302020-08-05$N/A$0.03$0.0256%
2020-03-312020-05-05$6.33 million$0.02$0.02-13.5%
2019-12-312020-02-25$6.22 million$0.01$0.0117%
2019-09-302019-11-05$6.62 million$0.04$0.01300%
2019-06-302019-08-06$5.35 million$0.03$0.0237.5%
2019-03-312019-04-30$4.97 million$0.02$0.0174%
2018-12-312019-02-12$4.27 million$0.03
2018-09-302018-10-23$4.55 million$0.01
2018-06-302018-08-06$0.01
2018-03-312018-05-07$0.01
2017-12-312018-02-13$0.01
2017-09-302017-09-30$0.01
2016-06-302016-08-31$-0.00
2016-03-312016-05-31-$0.01
2015-12-312016-02-29$0.01
2015-09-302015-11-30$0.00
2015-06-302015-08-31$0.01
2015-03-312015-05-31$-0.00
2014-12-312015-02-28$0.01
2014-09-302014-11-30$0.00
2014-06-302014-08-31$0.01
2014-03-312014-05-31$0.00
2013-12-312014-02-28$0.01
2013-09-302013-11-30$0.00
2013-06-302013-08-31$0.00
2013-03-312013-05-31$0.00
2012-12-312013-02-28$0.01
2012-09-302012-11-30$0.00
2012-06-302012-08-31$0.01
2011-12-312012-02-29$0.01
2011-09-302011-11-30$0.00
2011-06-302011-08-31$0.00
2011-03-312011-05-31$0.01
2010-12-312011-02-28$0.01
2010-09-302010-11-30$0.00
2010-06-302010-08-31$0.00
2010-03-312010-05-31$0.00
2009-12-312010-02-28$0.02
2009-09-302009-11-30$0.00
2009-06-302009-08-31$0.00
2009-03-312009-05-31$0.00
2008-12-312009-02-28$0.01
2008-09-302008-11-30$0.01
2008-06-302008-08-31$0.01
2008-03-312008-05-31$0.00
2007-03-312007-05-31-$0.01
2006-12-312007-01-22$0.00
2006-09-302006-10-13$-0.00
2006-06-302006-07-21$-0.00
2006-03-312006-05-31-$0.01
2005-12-312006-02-28$-0.00
2005-09-302005-11-30$0.00
2005-06-302005-08-31-$0.01
2005-03-312005-05-31-$0.01
2004-12-312005-02-28-$0.01
2004-09-302004-11-30$-0.00
2004-06-302004-08-31$-0.00
2004-03-312004-05-31$0.00
2003-12-312004-02-29$-0.00
2003-09-302003-11-30$-0.00
2003-06-302003-08-31$-0.00
2003-03-312003-05-31$-0.00
2002-12-312003-02-28-$0.01
2001-03-312001-05-31$-0.00
2000-03-312000-05-31$0.00
1999-09-301999-11-30$0.01
1999-03-311999-05-31-$0.01
1998-09-301998-11-30-$0.01

Repro Med Systems, Inc (KRMD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Repro Med Systems, Inc (KRMD) Chart:

Repro Med Systems, Inc (KRMD) News:

Below you will find a list of latest news for Repro Med Systems, Inc (KRMD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Repro Med Systems, Inc (KRMD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50.05CALL0 5674.16FALSE00
2024-05-1750.05CALL0 10FALSE00
2024-05-177.50CALL0 00FALSE00
2024-05-172.50PUT0 0125.72TRUE00
2024-05-1750PUT0 0298.86TRUE00
2024-05-177.50PUT0 0379.96TRUE00
2024-06-212.50CALL0 00FALSE00
2024-06-2150CALL0 00FALSE00
2024-06-217.50CALL0 00FALSE00
2024-06-212.50PUT0 0318.82TRUE00
2024-06-2150PUT0 0261.34TRUE00
2024-06-217.50PUT0 0348.92TRUE00
2024-08-162.50.5CALL0 6129.1FALSE00
2024-08-1650.5CALL0 0212.85FALSE00
2024-08-167.50CALL0 00FALSE00
2024-08-162.50.48PUT0 50218.46TRUE00
2024-08-1650PUT0 0344.6TRUE00
2024-08-167.50PUT0 0387.26TRUE00
2024-11-152.50.3CALL0 510FALSE00
2024-11-1550CALL0 00FALSE00
2024-11-157.50CALL0 00FALSE00
2024-11-152.50PUT0 00TRUE00
2024-11-1550PUT0 0685.82TRUE00
2024-11-157.50PUT0 0122.17TRUE00

Latest KRMD Trades:

Date Shares Price
Jun 13, 2022 4:14 PM EST100$2.01

Repro Med Systems, Inc (KRMD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000292/0001161697-20-000292-index.htm
2020-05-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/704440/000000000020004412/0000000000-20-004412-index.htm
2019-10-23424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/704440/000116169719000455/0001161697-19-000455-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169719000469/0001161697-19-000469-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169719000472/0001161697-19-000472-index.htm
2019-11-05424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/704440/000116169719000474/0001161697-19-000474-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/704440/000116169719000477/0001161697-19-000477-index.htm
2019-11-06424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/704440/000116169719000479/0001161697-19-000479-index.htm
2019-11-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169719000483/0001161697-19-000483-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169719000487/0001161697-19-000487-index.htm
2019-11-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/704440/000116169719000489/0001161697-19-000489-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000002/0001161697-20-000002-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000004/0001161697-20-000004-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000006/0001161697-20-000006-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000007/0001161697-20-000007-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000009/0001161697-20-000009-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000011/0001161697-20-000011-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000013/0001161697-20-000013-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000022/0001161697-20-000022-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000024/0001161697-20-000024-index.htm
2020-01-094/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000028/0001161697-20-000028-index.htm
2020-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000059/0001161697-20-000059-index.htm
2020-01-24424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/704440/000116169720000061/0001161697-20-000061-index.htm
2020-01-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/704440/000116169720000065/0001161697-20-000065-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000067/0001161697-20-000067-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000094/0001161697-20-000094-index.htm
2020-02-25424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/704440/000116169720000096/0001161697-20-000096-index.htm
2020-03-0410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/704440/000116169720000108/0001161697-20-000108-index.htm
2020-03-04POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/704440/000116169720000110/0001161697-20-000110-index.htm
2020-03-06DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000112/0001161697-20-000112-index.htm
2020-03-12424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/704440/000116169720000120/0001161697-20-000120-index.htm
2020-03-31DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/704440/000116169720000130/0001161697-20-000130-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000132/0001161697-20-000132-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000134/0001161697-20-000134-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000136/0001161697-20-000136-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000138/0001161697-20-000138-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000140/0001161697-20-000140-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000142/0001161697-20-000142-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000144/0001161697-20-000144-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000156/0001161697-20-000156-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000164/0001161697-20-000164-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000170/0001161697-20-000170-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000185/0001161697-20-000185-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/704440/000116169720000192/0001161697-20-000192-index.htm
2020-05-073/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000194/0001161697-20-000194-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000201/0001161697-20-000201-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000206/0001161697-20-000206-index.htm
2020-05-14S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/704440/000116169720000208/0001161697-20-000208-index.htm
2020-05-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/704440/000116169720000222/0001161697-20-000222-index.htm
2020-05-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000226/0001161697-20-000226-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000247/0001161697-20-000247-index.htm
2020-06-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/704440/000116169720000248/0001161697-20-000248-index.htm
2020-06-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/704440/000116169720000250/0001161697-20-000250-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000252/0001161697-20-000252-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000279/0001161697-20-000279-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000281/0001161697-20-000281-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000283/0001161697-20-000283-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000285/0001161697-20-000285-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000287/0001161697-20-000287-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000289/0001161697-20-000289-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000292/0001161697-20-000292-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000349/0001161697-20-000349-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/704440/000116169720000352/0001161697-20-000352-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000384/0001161697-20-000384-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000386/0001161697-20-000386-index.htm
2020-09-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000388/0001161697-20-000388-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000422/0001161697-20-000422-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000424/0001161697-20-000424-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000426/0001161697-20-000426-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000428/0001161697-20-000428-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000430/0001161697-20-000430-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000432/0001161697-20-000432-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/704440/000116169720000434/0001161697-20-000434-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/704440/000116169720000471/0001161697-20-000471-index.htm
2020-08-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/704440/000119312520225628/0001193125-20-225628-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/704440/000138713120001823/0001387131-20-001823-index.htm
2020-03-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/704440/999999999520000547/9999999995-20-000547-index.htm
2020-05-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/704440/999999999520001224/9999999995-20-001224-index.htm

Repro Med Systems, Inc (KRMD) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Repro Med Systems, Inc (KRMD). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1031%
Institutional Ownership: 6579%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-31Robert T AllenDirectorBuy833.007.506,247.5010,004.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000142/0001161697-20-000142-index.htm
2020-06-30Robert T AllenDirectorBuy696.008.986,250.0810,700.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000289/0001161697-20-000289-index.htm
2020-09-30Robert T AllenDirectorBuy866.007.226,252.5211,566.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000432/0001161697-20-000432-index.htm
2020-01-07Manuel A MarquesChief Operating OfficerBuy50,000.000.4623,000.00145,000.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000024/0001161697-20-000024-index.htm
2019-12-31R JOHN FLETCHERDirectorBuy1,914.006.5312,498.4220,856.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000007/0001161697-20-000007-index.htm
2020-03-31R JOHN FLETCHERDirectorBuy2,500.007.5018,750.0024,313.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000138/0001161697-20-000138-index.htm
2020-06-30R JOHN FLETCHERDirectorBuy2,088.008.9818,750.2426,401.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000285/0001161697-20-000285-index.htm
2020-01-07Manuel A MarquesChief Operating OfficerBuy125,000.000.5062,500.00270,000.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000024/0001161697-20-000024-index.htm
2020-09-30R JOHN FLETCHERDirectorBuy2,597.007.2218,750.3428,998.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000428/0001161697-20-000428-index.htm
2019-12-31David W AndersonDirectorBuy1,149.006.537,502.9735,104.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000004/0001161697-20-000004-index.htm
2020-03-31David W AndersonDirectorBuy1,000.007.507,500.0036,104.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000134/0001161697-20-000134-index.htm
2020-06-30David W AndersonDirectorBuy835.008.987,498.3036,939.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000281/0001161697-20-000281-index.htm
2020-09-30David W AndersonDirectorBuy1,039.007.227,501.5837,978.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000424/0001161697-20-000424-index.htm
2019-12-31James M BeckDirectorBuy1,149.006.537,502.9745,462.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000006/0001161697-20-000006-index.htm
2020-03-31James M BeckDirectorBuy1,000.007.507,500.0046,462.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000136/0001161697-20-000136-index.htm
2020-05-09Karen FisherChief Financial OfficerBuy435,000.000.38165,300.00472,156.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000201/0001161697-20-000201-index.htm
2020-06-30James M BeckDirectorBuy835.008.987,498.3047,297.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000283/0001161697-20-000283-index.htm
2020-09-30James M BeckDirectorBuy1,039.007.227,501.5848,336.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000426/0001161697-20-000426-index.htm
2020-05-09Karen FisherChief Financial OfficerBuy100,000.001.57157,000.00572,156.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000201/0001161697-20-000201-index.htm
2019-12-31Kathy FrommerDirectorBuy957.006.536,249.21704,184.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000009/0001161697-20-000009-index.htm
2020-03-31Kathy FrommerDirectorBuy833.007.506,247.50705,017.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000140/0001161697-20-000140-index.htm
2020-06-30Kathy FrommerDirectorBuy696.008.986,250.08705,713.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000287/0001161697-20-000287-index.htm
2020-09-30Kathy FrommerDirectorBuy866.007.226,252.52706,579.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000430/0001161697-20-000430-index.htm
2019-06-28Arthur J RadinInsiderBuy715.002.882,059.20715.00https://www.sec.gov/Archives/edgar/data/704440/000116169719000469/0001161697-19-000469-index.htm
2020-03-31Joseph M. Jr. MankoDirectorBuy1,000.007,368,381.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000144/0001161697-20-000144-index.htm
2020-06-30Joseph M. Jr. MankoDirectorBuy835.007,369,216.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000292/0001161697-20-000292-index.htm
2020-09-02Joseph M. Jr. MankoDirectorBuy6,500.007.4648,462.057,375,716.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000384/0001161697-20-000384-index.htm
2020-09-03Joseph M. Jr. MankoDirectorBuy25,000.007.26181,400.007,400,716.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000386/0001161697-20-000386-index.htm
2020-09-04Joseph M. Jr. MankoDirectorBuy25,000.007.25181,227.507,425,716.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000388/0001161697-20-000388-index.htm
2020-09-30Joseph M. Jr. MankoDirectorBuy1,039.007,426,755.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000434/0001161697-20-000434-index.htm
2019-12-31Joseph M. Jr. MankoDirectorBuy1,149.007,769,310.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000013/0001161697-20-000013-index.htm
2019-12-31Robert T AllenDirectorBuy957.006.536,249.219,171.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000011/0001161697-20-000011-index.htm
2019-12-31Daniel S GoldbergerDirectorBuy957.006.536,249.2195,879.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000002/0001161697-20-000002-index.htm
2020-03-31Daniel S GoldbergerDirectorBuy833.007.506,247.5096,712.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000132/0001161697-20-000132-index.htm
2020-06-30Daniel S GoldbergerDirectorBuy696.008.986,250.0897,408.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000279/0001161697-20-000279-index.htm
2020-09-30Daniel S GoldbergerDirectorBuy866.007.226,252.5298,274.00https://www.sec.gov/Archives/edgar/data/704440/000116169720000422/0001161697-20-000422-index.htm